drugset / Trial / NCT00365924
A Pilot Methodology Study To Evaluate Changes In Bone Quality Parameters Following Therapy With Forteo
Non-randomizedSingle-groupOpen-label
Summary
This methodology trial will be conducted in patients with osteoporosis and will measure the changes in bone quality parameters, micro- and macroarchitecture, bone biomarkers and bone density following therapy with the approved drug, Forteo.
Timeline
- Start
- 2006-12
- Primary completion
- —
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Teriparatide | Protein / enzyme biologic | — | — |